Yungjin Pharm Co Ltd (003520) — Cash Flow-to-Debt Ratio
Yungjin Pharm Co Ltd (003520) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of ₩7.00 Billion could theoretically repay 0% of its total liabilities (₩156.23 Billion) in one year. See 003520 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yungjin Pharm Co Ltd Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Yungjin Pharm Co Ltd across 12 annual periods. For the full cash flow conversion analysis, see 003520 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Yungjin Pharm Co Ltd (2013–2024)
Year-by-year debt coverage analysis for Yungjin Pharm Co Ltd. Check 003520 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.15x | ₩21.74 Billion | ₩144.45 Billion | ▲ +301.6% |
| 2023 | -0.07x | ₩-10.22 Billion | ₩136.97 Billion | ▲ +27.2% |
| 2022 | -0.10x | ₩-11.61 Billion | ₩113.21 Billion | ▼ -209.3% |
| 2021 | 0.09x | ₩8.37 Billion | ₩89.21 Billion | ▼ -52.3% |
| 2020 | 0.20x | ₩14.50 Billion | ₩73.67 Billion | ▲ +79.6% |
| 2019 | 0.11x | ₩9.28 Billion | ₩84.69 Billion | ▲ +626.9% |
| 2018 | 0.02x | ₩1.27 Billion | ₩84.51 Billion | ▼ -59.7% |
| 2017 | 0.04x | ₩3.15 Billion | ₩84.20 Billion | ▲ +12.1% |
| 2016 | 0.03x | ₩3.11 Billion | ₩93.19 Billion | ▼ -64.6% |
| 2015 | 0.09x | ₩8.80 Billion | ₩93.27 Billion | ▲ +18.7% |
| 2014 | 0.08x | ₩6.22 Billion | ₩78.18 Billion | ▼ -10.7% |
| 2013 | 0.09x | ₩5.95 Billion | ₩66.89 Billion | — |